Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer-Reference-Cited by-同舟云学术

Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer

Published:2021-09-06 Issue:12 Volume:60 Page:1580-1588
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Ekström Anders¹²^ORCID,Brun Eva¹³,Eberhard Jakob¹³,Segerlantz Mikael⁴⁵

Affiliation:

1. Department of Clinical Sciences, Oncology and Pathology, Faculty of Medicine, Lund University, Lund, Sweden

2. Department of Oncology, Blekinge Hospital, Karlskrona, Sweden

3. Department of Oncology, Skåne University Hospital, Lund, Sweden

4. Department of Clinical Sciences Lund, Oncology and Pathology, Institute for Palliative Care, Faculty of Medicine, Lund University, Lund, Sweden

5. Department of Palliative Care and Advanced Home Health Care, Primary Health Care Skåne, Region Skåne, Lund, Sweden

Funder

Vetenskapliga Rådet, Blekinge Hospital

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1973680

Reference32 articles.

1. Global Cancer Observatory [Internet]. Sweden. 2018; [cited 2021 Aug 26]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/752-sweden-fact-sheets.pdf.

2. A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs

3. ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up.

4. FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies

5. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer;Hepatobiliary Surgery and Nutrition;2024-06

2. Multifunctional Theranostic Probe Based on the Pim-1 Kinase Inhibitor with the Function of Tracking pH Fluctuations during Treatment;Analytical Chemistry;2023-07-25

3. The expectations of metastatic cancer patients regarding palliative chemotherapy: A Brazilian–German qualitative study;Palliative and Supportive Care;2023-01-06

4. Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer;Cancers;2023-01-05

5. Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens;Therapeutic Advances in Medical Oncology;2023-01